SYNVISC
Live / Registered — Registered and renewed (as of 17 Feb 2017)
What this means for you
Registered since 25 Nov 1986. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 25 Nov 2016).
Record
- Serial number
- 73597580
- Registration number
- 1418125
- Mark type
- Word mark
- Filed
- 08 May 1986
- Published for opposition
- 02 Sept 1986
- Registered
- 25 Nov 1986
- Next maintenance due
- 25 Nov 2016
- Attorney of record
- Karen Lim
Goods and services
- Class 005 — Pharmaceuticals: PHARMACEUTICALS, NAMELY PREPACKAGED INJECTABLE BIOCHEMICAL SOLUTIONS, NAMELY SODIUM HYLAN SOLUTIONS
- Class 010 — Medical apparatus: MEDICAL APPARATUS, NAMELY A SELF-CONTAINED SYRINGE FOR DISPENSING PREPACKAGED INJECTABLE SODIUM HYLAN SOLUTIONS FOR USE IN SURGERY
Owner
- GENZYME CORPORATION, Cambridge, MA, US
- BIOMATRIX, INC., Cambridge, MA, US
- BIOMATRIX, INC., RIDGEFIELD, NJ, US
- BIOMATRIX, INC., RIDGEFIELD, NJ, US
Prosecution history
- 25 Nov 2025 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 08 Jan 2020 — REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
- 10 Dec 2019 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 12 Apr 2019 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 12 Apr 2019 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 05 Apr 2017 — REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
- 31 Jan 2017 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 17 Feb 2017 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 17 Feb 2017 — REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
- 17 Feb 2017 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 17 Feb 2017 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 16 Dec 2016 — TEAS SECTION 8 & 9 RECEIVED
- 29 Sept 2006 — CASE FILE IN TICRS
- 25 Aug 2006 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 25 Aug 2006 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED